MEDIVEST INC
10QSB, 1999-04-28
DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Previous: HALSEY DRUG CO INC/NEW, 10-K/A, 1999-04-28
Next: OPPENHEIMER BOND FUND FOR GROWTH /MA/, 485BPOS, 1999-04-28







































                 U. S. Securities and Exchange Commission
                         Washington, D. C.  20549

                              FORM 10-QSB

[X]  QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
     EXCHANGE ACT OF 1934

     For the quarter ended March 31, 1999
                           --------------

[ ]  TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
     EXCHANGE ACT OF 1934 

     For the transition period from               to
                                    -------------    -------------

                        Commission File No. 1-10077
                                            -------

                                MEDIVEST, INC.     
                                --------------
              (Name of Small Business Issuer in its Charter)

         UTAH                                            87-0401761
         ----                                            ----------         
(State or Other Jurisdiction of                     (I.R.S. Employer I.D. No.)
 incorporation or organization)

                        11011 King Street, Suite 260
                        Overland Park, Kansas 66210
                        ---------------------------    
                 (Address of Principal Executive Offices)

                Issuer's Telephone Number:  (913) 469-5615

                                    N/A
                                    ---      
       (Former Name or Former Address, if changed since last Report)

     Check whether the Issuer (1) filed all reports required to be filed by
Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such
shorter period that the Company was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.  

     (1)   Yes  X    No            (2)   Yes  X    No 
               ---      ---                  ---      ---

               (ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS 
                       DURING THE PAST FIVE YEARS)

     Check whether the issuer has filed all documents and reports required to
be filed by Section 12, 13 or 15(d) of the Exchange Act after the distribution
of securities under a plan confirmed by a court.  Yes  X    No 
                                                      ---     ---
                   (APPLICABLE ONLY TO CORPORATE ISSUERS)

          State the number of shares outstanding of each of the Issuer's
classes of common equity, as of the latest practicable date:

                                April 27, 1999

                           Common - 4,372,639 shares
          
                    DOCUMENTS INCORPORATED BY REFERENCE

          A description of any "Documents Incorporated by Reference" is
contained in Item 6 of this Report.

Transitional Small Business Issuer Format   Yes  X   No 
                                                ---     ---

                  PART I - FINANCIAL INFORMATION

Item 1.   Financial Statements.

          The Consolidated Financial Statements of the Company required
to be filed with this 10-QSB Quarterly Report were prepared by management and
commence on the following page, together with related Notes.  In the opinion
of management, the Consolidated Financial Statements fairly present the
financial condition of the Company.
<TABLE>
                                MEDIVEST, INC.
                        (A Development Stage Company)
                                BALANCE SHEETS
<CAPTION>
                                                    (Unaudited)
                                                     March 31,  December 31,
                                                       1999         1998
<S>                                                 <C>          <C>
Assets
    Cash and Cash Equivalents                        $  3,784    $ 5,000

Total Assets                                         $  3,784    $ 5,000

Liabilities and Stockholders' Equity
    Liabilities
    Accounts Payable                                    4,622    $   705
    Income Tax Payable                                      -        100

Total Liabilities                                       4,622        905

Stockholders' Equity
Common Stock, authorized
    50,000,000 shares of $.001
    par value, issued and outstanding
    4,372,639 as of March 31,
    1999 and December 31, 1998                          4,373      4,373

    Additional Paid in Capital                      1,675,788  1,675,788
    Previous Retained Deficit                      (1,867,999)(1,867,999)
    Earnings(Deficit)Accumulated During Development 
    Stage                                             187,000    192,033
         Total Stockholders' Equity                      (838)     4,195
Total Liabilities and Stockholders' Equity              3,784      5,000
</TABLE>
The accompanying notes are an integral part of these financial statements.
<TABLE>
                              MEDIVEST, INC.
                       (A Development Stage Company)
                         STATEMENTS OF OPERATIONS
                                (Unaudited)
<CAPTION>
                                                               Cumulative
                                                                  Since
                                                                Inception
                                    For the Three Months Ended      of
                                      March 31,   March 31,     Development
                                        1999        1998          Stage
<S>                                  <C>          <C>          <C>
Revenues

General and Administrative Expenses   (5,033)     (2,897)       (68,228)

Net Loss Before Taxes and 
Extraordinary Item                    (5,033)     (2,897)       (68,228)
Net Taxes                                                          (300)

Net Loss Before Extraordinary Item    (5,033)     (2,897)       (68,528)

Extraordinary Item - Gain on 
Restructuring of Debt, Net of Taxes                             255,528

Net Income (Loss)                     (5,033)     (2,897)       187,000

Earnings (Loss) Per Common Share         -           -

Weighted Average shares Outstanding 4,372,639   1,301,305
</TABLE>
The accompanying notes are an integral part of these financial statements.
<TABLE>
                              MEDIVEST, INC.
                       (A Development Stage Company)
                         STATEMENTS OF CASH FLOWS
                                (Unaudited)
<CAPTION>
                                                                Cumulative
                                                                   Since
                                    For the Three Months Ended   Inception
                                        March 31,  March 31,         Of
                                          1999        1998      Development
<S>                                   <C>         <C>          <C>             
Cash Flows From Operating
Net Income (Loss)                      $(5,033)     $ (2,897)    $ 187,000
Adjustments to Reconcile Net Income to
Net Cash Provided by Operating Activities:
  Common stock issued for services           -             -        21,400
  Common Stock issued for finance charges    -             -        17,587
Changes in Assets and Liabilities
  Increase (Decrease) in accounts 
  payable                                3,917         2,997         4,622
  Increase (Decrease) in other 
  liabilities                                -             -      (276,825)
    Increase (Decrease) in taxes payable  (100)         (100)            -
Net Cash Used by Operating Activities   (1,216)            -       (46,216)

Cash Flows From Investing Activities         -             -             -

Cash Flows From Financing Activities
Proceeds issuance of common stock            -             -        50,000
Net (decrease) in cash and cash 
equivalents                             (1,216)            -         3,784
Cash and cash equivalents at beginning 
of year                                  5,000             -             -

Cash and cash equivalents at end of year 3,784             -         3,784
</TABLE>
The accompanying notes are an integral part of these financial statements.

                              MEDIVEST, INC.
                       (A Development Stage Company)
                     NOTES TO THE FINANCIAL STATEMENTS
                  For the Three Months Ended March 31, 1999
                                 (Unaudited)

 NOTE 1 - INTERIM REPORTING
 
 The accompanying unaudited financial statements have been prepared in
 accordance with generally accepted accounting principles and with Form 10-QSB
 requirements. Accordingly, they do not include all of the information and     
 footnotes required by generally accepted accounting principles for complete   
 financial statements. In the opinion of management, all adjustments           
 considered necessary for a fair presentation have been included. Operating    
 results for the three months period ended March 31, 1999, are not necessarily 
 indicative of the results that may be expected for the year ended December    
 31, 1999.

Item 2.   Management's Discussion and Analysis or Plan of Operation.

Plan of Operation.

      The Company has not engaged in any material operations or
had any revenues from operations during the last two calendar years. The
Company's plan of operation for the next 12 months is to continue to seek the
acquisition of assets, properties or businesses that may benefit the Company
and its stockholders. Management anticipates that to achieve any such
acquisition, the Company will issue shares of its common stock as
the sole consideration for any such acquisition.

     During the next 12 months, the Company's only foreseeable cash
requirements will relate to maintaining the Company in good standing or the
payment of expenses associated with reviewing or investigating any potential
business venture.  Such funds may be advanced by management or stockholders as
loans to the Company.  Because the Company has not identified any such venture
as of the date of this Report, it is impossible to predict the amount of any
such loans or advances.  However, any such loans or advances should not exceed
$25,000 and will be on terms no less favorable to the Company than would be
available from a commercial lender in an arm's length transaction.   As of the
date of this Report, the Company is not involved in any negotiations
respecting any such venture.  

Results of Operations.
- ----------------------

     Other than restoring and maintaining its good corporate standing in the
State of Utah, compromising and settling its debts and seeking the acquisition
of assets, properties or businesses that may benefit the Company and its
stockholders, the Company has had no material business operations during the
two most recent calendar years.

     During the quarters ended March 31, 1999 and 1998, the Company had no
business operations, a net loss of ($5,033) and ($2,897), respectively, and
liabilities of $4,622 for March 31, 1999.

Liquidity.
- ---------

     On March 31, 1999, the Company had $3,784 in cash with $4,622 in total
liabilities.

                   PART II - OTHER INFORMATION

Item 1.   Legal Proceedings.

          None; not applicable.

Item 2.   Changes in Securities.

         None; not applicable.

Item 3.   Defaults Upon Senior Securities.

          None; not applicable.

Item 4.   Submission of Matters to a Vote of Security Holders.

          No matter was submitted to a vote of the Company's security holders
during the first quarter of the calendar year covered by this Report or
during the two previous calendar years.

         However, an Information Statement was mailed to the stockholders on
April 26, 1999, regarding changing the name of the Registrant to "Empire
Energy Corporation."  The Information Statement is incorporated herein by
reference.

Item 5.   Other Information.

          None; not applicable.

Item 6.   Exhibits and Reports on Form 8-K.
                    
        
                                                         Page
          (a)  Exhibits.*                               Number
               
             Information Statement                     **

          (b)  Reports on Form 8-K.

             An 8-K Current Report dated March 15, 1999, was filed with the  
             Securities and Exchange Commission on March 24, 1999, regarding 
             a change in control of the Company and the resignations of the  
             directors and executive officers.

      *   A summary of any Exhibit is modified in its entirety by reference
          to the actual Exhibit.

     **  These documents and related exhibits have been previously filed      
         with the Securities and Exchange Commission and are incorporated      
     herein by reference. 


                            SIGNATURES

          Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this Report to be signed on its behalf by
the undersigned thereunto duly authorized.

                                       MEDIVEST, INC.



Date: 4/27/99                          By/s/Norman L. Peterson
      ----------                        -------------------------------------- 
                                        Norman L. Peterson
                                        President and Director



          Pursuant to the requirements of the Securities Exchange Act of 1934,
as amended, this Report has been signed below by the following persons on
behalf of the Company and in the capacities and on the dates indicated:


                                        MEDIVEST, INC.




Date: 4/27/99                           By/s/Norman L. Peterson
     ----------                          ------------------------------------
                                         Norman L. Peterson
                                         President and Director
                                         

Date: 4/27/99                           By/s/John R. Dixon
     ----------                          ------------------------------------
                                         John R. Dixon
                                         Vice President and Director


Date: 4/28/99                           By/s/John G. Garrison
     ----------                          ------------------------------------
                                         John G. Garrison
                                         Secretary and Director


Date: 4/28/99                           By/s/John L. Hersma
     ----------                          ------------------------------------
                                         John L. Hersma
                                         Director


Date: 4/28/99                           By/s/Elliot M. Kaplan   
     ----------                          ------------------------------------
                                         Elliot M. Kaplan
                                         Director


<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               MAR-31-1999
<CASH>                                            3784
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                    3784
<CURRENT-LIABILITIES>                             4622
<BONDS>                                              0
                                0
                                          0
<COMMON>                                          4373
<OTHER-SE>                                       (5211)
<TOTAL-LIABILITY-AND-EQUITY>                      3784
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                  5033
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                  (5033)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (5033)
<EPS-PRIMARY>                                     (.00)
<EPS-DILUTED>                                     (.00)
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission